IP Library Granted Patent US 10,352,890
Granted Patent B2
US 10,352,890 · App. 15/797,765 · Granted Jul 16, 2019

Biosensor system, sensor chip, and method of measuring analyte concentration in blood sample

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,352,890
App. No.
15/797,765
Granted
Jul 16, 2019
Kind
B2
Abstract

The present invention provides a biosensor system that can prevent a measurement error caused by the temperature of the environment in use from occurring. A biosensor system 100 includes a measuring instrument 101 having an operation part 306 , and a sensor chip 200 that is insertable into and removable from the measuring instrument 101 and into which a blood sample is introduced. The sensor chip 200 includes a measurement part 41 (a measurement part A) that acquires Data a related to the concentration of an analyte in a blood sample based on the amount of electric current that flows in the blood sample due to a reaction in which an oxidoreductase with the analyte used as a substrate is involved, and a measurement part 42 (a measurement part B) that acquires, from the blood sample, Data b for temperature correction of Data a. The operation part 306 has a function of determining the concentration of the analyte in the blood sample, with the concentration having been corrected according to the temperature of the blood sample based on Data a and Data b.

Claims (22)

1. A biosensor system, comprising:

a measuring instrument having an operation part; and

a sensor chip that is insertable into and removable from the measuring instrument, and comprises:

a capillary part that holds a blood sample introduced into the sensor chip;

a measurement part A including an electrode A and an electrode B in the capillary part;

a measurement part B including the electrode A and an electrode C in the capillary part;

a reaction reagent layer formed on the electrodes A and B but not on the electrode C; and

a spacer formed on the reaction reagent layer, wherein

the operation part has a conversion table established using a relationship where the amount of electric current that flows in a blood sample due to the reaction involving the oxidoreductase with the analyte used as a substrate varies in the same manner as the amount of electric current that flows in a blood sample according to oxidation or reduction of a redox substance other than the analyte, when the temperature of the blood sample varies,

the measurement part A acquires Data a related to a concentration of an analyte in the blood sample based on the amount of electric current that flows in the blood sample due to a reaction in which an oxidoreductase with the analyte used as a substrate is involved;

the measurement part B acquires Data b suitable for temperature correction of the Data a, and

the operation part is configured to determine the concentration of the analyte in the blood sample based on the Data a, as corrected based on the Data b measured by measurement part B, thereby avoiding the influence of the temperature of the blood sample in the measurement of the analyte concentration with reference to the conversion table.

2. The biosensor system according to claim 1 , wherein the electrodes A, B and C are formed of conductive materials selected from the group consisting of palladium, platinum, gold, silver, titanium, copper, nickel and carbon.

3. The biosensor system according to claim 1 , wherein the spacer has the capillary part, and a height of the capillary part is 0.05 mm to 0.3 mm.

4. The biosensor system according to claim 1 , wherein the measuring instrument has a control circuit that provides the measurement part A with a signal that indicates acquisition of the Data a within a range of at least 0.5 second but less than 2.5 seconds from the time when the blood sample has been introduced into the sensor chip.

5. The biosensor system according to claim 1 , wherein the reaction reagent layer contains the oxidoreductase,

the reaction reagent layer contains no water-soluble polymer or contains less than 0.2 mass % of water-soluble polymer, and

the measuring instrument has a control circuit that provides the measurement part A with a signal that indicates acquisition of the Data a within a range of at least 0.5 second but less than 2.5 seconds from the time when the blood sample has been introduced into the sensor chip.

6. The biosensor system according to claim 1 , wherein the reaction reagent layer contains the oxidoreductase,

the reaction reagent layer contains at least 0.2 mass % of water-soluble polymer, and

the measuring instrument has a control circuit that provides the measurement part A with a signal that indicates acquisition of the Data a after a lapse of at least 2.5 seconds from the time when the blood sample has been introduced into the sensor chip.

7. The biosensor system according to claim 1 , wherein the electrode A is a working electrode for the measurement part A and a counter electrode for the measurement part B.

Assignments (1)
CHANGE OF NAME Recorded Aug 6, 2018
From: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
To: PHC HOLDINGS CORPORATION
Reel/Frame 046724/0122 →